Egg Donation Market By Donor Type (Agency-Based Donors, Clinic-Based Donors, Independent Donors), By Application (Infertility Treatment, Delayed Parenthood, Same-Sex Couples, Medical Conditions), By Donation Type (Fresh Egg Donation, Frozen Egg Donation), By Treatment Type (In Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), Artificial Insemination (AI), Surrogacy), By End User (Fertility Clinics, Hospitals, Cryobanks, Research Institutes), Global Market Size, Segmental Analysis, Regional Overview, Company Share Analysis, Leading Company Profiles, and Market Forecast, 2025–2035.

---

What trends will shape this market in the coming years?

The Egg Donation Market accounted for USD 2.82 Billion in 2024 and USD 3.05 Billion in 2025 is expected to reach USD 6.79 Billion by 2035, growing at a CAGR of around 8.32% between 2025 and 2035. The Egg Donation Market is an industry that exists to help people become parents by donating and using eggs to assist all parties involved. As a fertility treatment, egg donation involves donors who provide eggs that become implanted in recipient's womb for various reasons, including infertility, delayed childbearing, same-sex parenting, or specific medical needs. The market includes three segments regarding donor categories (agency-based, clinic-based, independent), donation options (fresh eggs or frozen eggs, and necessary procedures along with IVF, ICSI, along surrogacy. Prolific demand from fertility clinics, hospitals, cryobanks, and research institutes fuels global market growth because assisted reproductive technologies help transform reproductive possibilities for potential parents.

What do industry experts say about the market trends?

“The availability of donor eggs has expanded the possibilities for family building, providing options for women who may not have viable eggs of their own.”

• Dr. David Adamson, President of the American Society for Reproductive Medicine.

“Egg donation has revolutionized the treatment of infertility, offering hope to many who might otherwise remain childless.”

• Dr. Alan B. Copperman, Director of the Division of Reproductive Endocrinology and Infertility at Mount Sinai Health System

Which segments and geographies does the report analyze?

What are the key drivers and challenges shaping the market?

What advancements accelerate success rates in assisted reproductive technologies?

Advances in assisted reproductive technology have permitted a significant increase in the success rate in egg donation cycles. These include enhanced ovarian stimulation protocols, faster freezing styles of preservation such as vitrification for eggs and embryos, and preimplantation genetic testing (PGT), which ensures higher rates of implantation and live births by sorting embryos better. CDC statistics say that using frozen donor eggs has steadily increased live birth rates to around 50-60% per transfer for women aged under 35 years over recent years.

SART claims that with the enterprising effect of vitrification, the damage to the eggs during freezing has been lowered, thus improving survival after thawing to greater than 90%. In addition, improved circumstances for embryo culture coupled with time-lapse imaging permit embryologists to select embryos most worthy of implementation, thereby ameliorating results. The NIH also cites such technologies as cutting down the number of cycles required to produce a pregnancy and cutting physical and financial burdens on the patient.

Can increased awareness improve acceptance and participation in egg donation?

In the pursuit of awareness, a pivotal element emerges: acceptance and participation in egg donation. Some women are unsure of their decision because of a veiled awareness of the process, its safety, and its benefits. Therefore, it perplexes and fills them with apprehension. Health institutions, together with governments, have run educational campaigns to dispel myths and educate potential donors on, and against, medical and ethical concerns. Data from the Centers for Disease Control and Prevention (CDC) in the United States illustrate that an increase in public awareness about egg donation correlates with a rise in voluntary egg donations by the general public over the last ten years.

Information-sharing that is transparent in regard to screening and donor rights helps produce more willing donors, reports the Society for Assisted Reproductive Technology (SART). This trust is further galvanised by government regulations, such as the ART regulations within India and the US, that enforce standards of safety. When women are better informed through credible educational and government sources, acceptance and participation in egg donation significantly improve.

How do high medical costs reduce accessibility for many patients?

Egg donation access is highly influenced by the high medical costs, which limit low-income earners. The treatments include hormonal therapies and IVF, whose cycle ranges between $12,000 and $15,000 in the U.S. and might exclude medication costs. According to the CDC, these charges often go beyond what many families can afford for egg donation. And hardly more than 15 states in the U.S. require insurance companies to cover fertility treatments, according to the National Conference of State Legislatures (NCSL), so many must shoulder the costs themselves.

The WHO has also noted that affordability is a major barrier around the world in infertility care, especially within low- and middle-income countries. The high costs that form obstacles create inequities for people seeking reproductive healthcare, so that many individuals with the need for egg donation cannot take advantage thereof. Accordingly, such financial limitations stymie market growth, patient accessibility, and retention in the fields.

Could expanding fertility tourism create new markets for egg donation?

Fertility tourism, if widened, could very well open up the egg donation markets by travelling overseas to countries that entertain egg donations under favourable regulations, being cheap in monetary terms, and upholding high standards of medical care. An increase in egg demand is thereby possible in countries that have a thriving fertility tourism infrastructure because of the growing number of couples and individuals seeking help with reproduction worldwide. Although over twenty thousand ART cycles involving donor eggs were carried out in the U.S. alone in 2020, according to the CDC, the use of egg donation has been growing steadily.

Further, cross-border fertility treatments are being propelled by the WHO's declaration of infertility as a global health issue. Countries that offer cheaper treatment methods and transparent, ethical donor programs stand to gain from this trend, contributing to the diversification and dynamism of the egg donation market. That sort of growth addresses patient needs and gets incentives to improve donor recruitment and healthcare standards, thereby widening access and options for infertility patients on a global scale.

How can digital platforms simplify donor-recipient matching processes efficiently?

Digital platforms can considerably reduce the complexity of communication in the process of donor-recipient matching for egg donation, therefore enabling less friction in communication and more speed in matching appropriate donors with recipients. These platforms implement enhanced algorithms that draw from vast databases containing genetic, medical, and personal profiles to secure the best possible matches and thereby eliminate much of the time required for traditional manual searches.

NIH confirms that digital health technologies have improved patient outcomes and workflows in reproductive health services. These platforms further permit confidential and secure viewing of donor data, easing the recipient's ability to make informed decisions. By systematically migrating donor data and procedures into an automated tool, fertility clinics are saved from cumbersome administrative tasks while also giving donors increased transparency, a win-win situation for all concerned parties. This amplifies the spirit encouraged in telemedicine, which has been endorsed well by health services with over a 50% usage increase since 2020, according to the CDC.

What are the key market segments in the industry?

Based on the Donor type, the Egg donation market is classified into Agency-Based Donors, Clinic-Based Donors, and Independent Donors. Agency-based donors maintain a substantial market position due to their systematic and supervised operational framework that safeguards donor and recipient connections while providing complete screening procedures. The high number of well-screened donors, combined with their ability to match traits, leads agency donors to attract specific recipients. Responsible agency supervision combined with professional standards builds trust in the donation process, making this approach the dominant choice among recipients. The increasing necessity for reliable egg donation services with transparent systems keeps agency-based donors as the selected market solution.

Based on the Application, the Egg donation market is classified into Infertility Treatment, Delayed Parenthood, Same-Sex Couples, and Medical Conditions.  The sector generates the most revenue because embryo donation stands as a transformational solution for increasing numbers of infertile couples. The growing worldwide infertility problem, particularly due to age-related factors, drives numerous women together with couples towards choosing egg donation to achieve pregnancy. Fertility treatments using donor eggs serve as the main market driver, which establishes infertility treatment as the major and most prevalent application area. The growth of this trend will persist because reproductive medicine continues to reach higher success rates through advancement. 

Which regions are leading the market, and why?

The North American Egg donation market is leading because of increasing interest in fertility treatment options among patients. The United States demonstrates market leadership because of its sophisticated healthcare infrastructure combined with large-scale acceptance of assisted reproductive technologies and an extensive framework of egg donation agencies. Delayed parenthood, together with rising infertility rates, continues to drive the upward trend in egg donation service requirements.

The recognized legal framework and ethical regulations throughout North America create security for donors and recipients, thus enhancing overall market confidence. The egg donation market in Canada continues to grow thanks to expanded fertility education and improved accessibility of healthcare. The willingness of recipients from diverse global backgrounds to receive egg donation treatment fuels North America's growth in the donation services industry. Market projections indicate that North American fertility treatments will continue to grow, which will make the market a central force within the region.  

The Asia-Pacific (APAC) Egg donation market is expanding because of increasing rates of infertility as well as increasing awareness about assisted reproductive technologies (ART). The markets of India, Thailand, and Australia lead this growth because they provide affordable healthcare treatment supported by knowledgeable providers and more accommodating regulatory practices. India stands as one of the prime international choices for egg donation services because of its affordable healthcare delivery combined with skilled biomedical specialists. Australia allows egg donation practice according to laws that maintain both donors' and recipients' safety through strict ethical criteria.

The area's increasing need for assisted reproductive technologies emerged due to two key events: advancing attitudes toward age-related parenthood and expanding acceptance of fertility treatment methods. The expansion of the market encounters obstacles in specific nations because of weak legal structures and cultural resistance, alongside inconsistent access to advanced fertility services. The APAC region will experience continuing expansion in the fertility market despite current obstacles because governments commit more funds to build fertility clinics while intensifying awareness initiatives.

What does the competitive landscape of the market look like?

The egg donation market is highly competitive, with Egg Donor Program alongside California Cryobank, New Hope Fertility Center, and CCRM (Colorado Center for Reproductive Medicine). Different market leaders provide full egg donation programs to patients through genetic screening as well as advanced reproductive technology and donor and recipient matching systems. California Cryobank recently extended its donor egg program to international markets because it wants to provide services to the increasing worldwide demand.

ew Hope Fertility Center leads the industry through its innovative freezing techniques that generate higher success rates and position it as the field's premier player. Through strategic partnerships with fertility clinics throughout North America, CCRM has expanded its market footprint. Service providers face intense competition because technological progress with regulatory developments continuously improve both donor service delivery and donor-recipient matching capability.

Egg Donation Market, Company Shares Analysis, 2024

To explore in-depth analysis in this report - Request Sample Report

Which recent mergers, acquisitions, or product launches are shaping the industry?

• In March 2025, Lushi, founded by Jessica Schaefer, launched a streamlined fertility platform. It offered concierge-level services like hormone tracking, bloodwork, at-home nurse injections, and 24/7 AI support. The platform aimed to simplify the egg-freezing and IVF process. The cost was around $18,000 per cycle.
• In December 2024, Bloomberg investigated the global trade of human eggs, highlighting concerns about the exploitation of women in countries like India, Argentina, Greece, and Taiwan.
• In October 2024, Forbes reported that a startup is expanding the egg donation market beyond traditional college student donors, offering financial incentives to young, healthy individuals to donate eggs.

Report Coverage:

By Donor Type

• Agency-Based Donors
• Clinic-Based Donors
• Independent Donors

By Application

• Infertility Treatment
• Delayed Parenthood
• Same-Sex Couples
• Medical Conditions

By Donation Type

• Fresh Egg Donation
• Frozen Egg Donation

By Treatment Type

• In Vitro Fertilization (IVF)
• Intracytoplasmic Sperm Injection (ICSI)
• Artificial Insemination (AI)
• Surrogacy

By End-User

• Fertility Clinics
• Hospitals
• Cryobanks
• Research Institutes

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of the Middle East & Africa

List of Companies:

• Shady Grove Fertility
• Donor Egg Bank USA
• Egg Donor America
• The World Egg Bank
• Circle Surrogacy & Egg Donation
• Growing Generations
• Extraordinary Conceptions
• Ovobank
• Cryos International
• Fertility Source Companies
• Elite Fertility Solutions
• ConceiveAbilities
• Donor Concierge
• Conceptual Options
• New Life Egg Bank

Frequently Asked Questions (FAQs)